GlassScriptPhysician profile
Fawaz H Abass
NPI 1184336869
$2,704.01
in general payments reported to CMS, 2019-2025
20 companies · $1,236 in 2025
The $1,236 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $28.93 · 2024: $1,439 · 2025: $1,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,704.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $506.85 | 2024-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.56 | 2024-2025 | Jardiance |
| Amgen INC. | $288.20 | 2023-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $262.67 | 2024-2025 | |
| Cvrx, INC. | $253.15 | 2024 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $219.04 | 2025 | Amvuttra, Onpattro |
| Pfizer INC. | $173.42 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $160.81 | 2024-2025 | Farxiga, Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $108.20 | 2025 | |
| Merck Sharp & Dohme LLC | $77.44 | 2024-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $59.25 | 2025 | Uptravi |
| Esperion Therapeutics, INC. | $42.37 | 2024 | Nexletol |
| Janssen Pharmaceuticals, INC | $37.18 | 2024 | Xarelto |
| Glaxosmithkline, LLC. | $28.06 | 2025 | Shingrix, Arexvy |
| Scpharmaceuticals INC. | $24.74 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altathera Pharmaceuticals LLC | $24.35 | 2025 | Sotalol Hydrochloride |
| Lilly USA, LLC | $18.99 | 2025 | Zepbound |
| Heartflow, INC. | $18.85 | 2025 | |
| Inari Medical, INC. | $16.39 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $14.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fawaz Abass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.